| 000 | 01262nam a2200313 a 4500 | ||
|---|---|---|---|
| 005 | 20250914141740.0 | ||
| 008 | 050923 2005 moua 000 0 eng d | ||
| 020 |
_a1574392220 _cRM273.73 |
||
| 039 | 9 |
_a200608031551 _brapiza _c200510260935 _djufri _c200510211534 _dazlan _c200510211533 _y09-23-2005 _zdiyana |
|
| 060 |
_aQV39 _b.H2514m 2005 |
||
| 090 | _aQV39.H2514m 2005 9 | ||
| 100 | 1 | _aHansten, Philip D. | |
| 245 | 1 | 0 |
_aManaging clinically important drug interactions / _cPhilip D. Hansten, John R. Horn. |
| 246 | _aHansten and Horn managing clinically important drug interactions | ||
| 260 |
_aSt. Louis, Mo. : _bFacts & Comparisons, _c2005 |
||
| 300 |
_axiii, 713 p. ; _c23 cm. |
||
| 500 | _aAdapted from Hansten and Horn's Drug Interactions Analysis and Management loose-leaf information service through the january 2005 update | ||
| 650 | 2 |
_aDrug Interactions _vhandbooks |
|
| 650 | 2 |
_aDrug therapy _xAdverse effects |
|
| 700 | 1 | _aHorn, John R. | |
| 907 |
_a.b13615968 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV39.H2514m 2005 9 |
||
| 914 | _avtls003315186 | ||
| 990 | _adiyana/Azlan | ||
| 991 | _aJabatan Farmasi, HUKM | ||
| 991 | _aJabatan Farmasi, KKL | ||
| 998 |
_ad _ah _b2005-10-09 _cm _da _feng _gmou _y0 _z.b13615968 |
||
| 999 |
_c360512 _d360512 |
||